Share

Stem Cells Show Promise in Treating Late-Onset Hypogonadism

Directed differentiation of human induced pluripotent (hiPSCs) into Leydig-like cells may be a novel and promising treatment for late-onset hypogonadism (LOH), according to a study recently published in Endocrinology. Researchers led by Takashi Aoi, MD, PhD, of Kobe University in Japan, point out that LOH is characterized by various symptoms, including erectile dysfunction, decreased muscle...
Share

Shock to the System: Pediatric Type 1 Diabetes Patients and Trauma

A new study seems to suggest that while trauma and post-traumatic stress syndrome are common in kids with type 1 diabetes, they have little to no impact on their diabetes self-management. However surprising this finding may be to researchers, it further stresses the need for multidisciplinary teams to care for these patients. Children suffering traumatic...
Share

The Time Is Always Now: The Endocrine Society’s Call to Eliminate Racism in Endocrinology

march 2022 cover With the publication of “Eradicating Racism in Endocrinology: An Endocrine Society Policy Perspective” in the January issue of The Journal of Clinical Endocrinology & Metabolism, the Endocrine Society formally calls for policies to address racial and ethnic inequities in the endocrine workforce and in access to care. James Baldwin began his 1956 essay “Faulkner and...